The National Service Framework for Coronary Heart Disease

The National Service Framework for Coronary Heart Disease

Cardiovascular disease is the most important cause of illness in Britain. The focus of the National Service Framework for Coronary Heart Disease (NSF for CHD) is appropriate since the burden of CHD is high in the UK. Interventions for primary and secondary prevention include advice on reducing modif...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoir:	Hobbs, R
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	2002

Míreanna comhchosúla

The National Service Framework on coronary heart disease
de réir: Hobbs, R
Foilsithe / Cruthaithe: (1999)

Response to the national service framework on coronary heart disease: Is it sufficiently evidence-based?
de réir: Hobbs, R
Foilsithe / Cruthaithe: (2001)

Response to the National Service Framework on coronary heart disease: is it sufficiently evidence-based?
de réir: Hobbs, F
Foilsithe / Cruthaithe: (2001)

Management of hyperlipidaemia in primary care: The implications of the National Service Framework for Coronary Heart Disease
de réir: Hobbs, R
Foilsithe / Cruthaithe: (2000)

Values underlying the National Service Framework for coronary heart disease in England: a discourse analysis
de réir: Rayner, M, et al.
Foilsithe / Cruthaithe: (2006)

Heart failure therapy in patients with coronary artery disease.
de réir: Taylor, C, et al.
Foilsithe / Cruthaithe: (2013)

Homocysteine and coronary heart disease.
de réir: Clarke, R, et al.
Foilsithe / Cruthaithe: (2002)

Blood pressure and coronary heart disease.
de réir: Collins, R, et al.
Foilsithe / Cruthaithe: (1990)

Heart rate variability in mice with coronary heart disease
de réir: Zapanta, Laurence (Laurence F.)
Foilsithe / Cruthaithe: (2006)

Paraoxonase polymorphisms and coronary heart disease.
de réir: Durrington, P, et al.
Foilsithe / Cruthaithe: (2004)

Postprandial lipaemia and coronary heart disease
de réir: Hamsten, A, et al.
Foilsithe / Cruthaithe: (1998)

LOW CHOLESTEROL AND CORONARY HEART-DISEASE - REPLY
de réir: Chen, Z, et al.
Foilsithe / Cruthaithe: (1991)

Homocysteine and prediction of coronary heart disease and stroke
de réir: Clarke, R, et al.
Foilsithe / Cruthaithe: (2003)

Trans fatty acids and coronary heart disease.
de réir: Clarke, R, et al.
Foilsithe / Cruthaithe: (2006)

Fire-and-forget in prevention of coronary heart disease.
de réir: Karpe, F, et al.
Foilsithe / Cruthaithe: (2002)

Plasma cholesterol, coronary heart disease, and cancer.
de réir: Peto, R, et al.
Foilsithe / Cruthaithe: (1989)

Paraoxonase polymorphisms and coronary heart disease - Reply
de réir: Wheeler, J, et al.
Foilsithe / Cruthaithe: (2004)

The economic burden of coronary heart disease in the UK.
de réir: Liu, J, et al.
Foilsithe / Cruthaithe: (2002)

Coronary heart disease and body fat distribution.
de réir: Canoy, D
Foilsithe / Cruthaithe: (2010)

The coronary heart disease in-patient experience questionnaire (I-PEQ (CHD)): results from the survey of National Health Service patients.
de réir: Jenkinson, C, et al.
Foilsithe / Cruthaithe: (2002)

Chronic infections and coronary heart disease: is there a link?
de réir: Danesh, J, et al.
Foilsithe / Cruthaithe: (1997)

Reducing social inequalities and the prevention of coronary heart disease.
de réir: Emberson, JR, et al.
Foilsithe / Cruthaithe: (2004)

Independent Relevance of Cytokines for Risk of Coronary Heart Disease
de réir: Clarke, R, et al.
Foilsithe / Cruthaithe: (2012)

Education and coronary heart disease: mendelian randomisation study.
de réir: Tillmann, T, et al.
Foilsithe / Cruthaithe: (2017)

Comparative trends in coronary heart disease subgroup hospitalisation rates in England and Australia
de réir: Nedkoff, L, et al.
Foilsithe / Cruthaithe: (2019)

Mendelian randomization of blood lipids for coronary heart disease.
de réir: Holmes, M, et al.
Foilsithe / Cruthaithe: (2014)

NK cell compartment in patients with coronary heart disease.
de réir: Hak, Ł, et al.
Foilsithe / Cruthaithe: (2007)

Metabolomics and coronary heart disease risk in UK Biobank
de réir: Jin, D
Foilsithe / Cruthaithe: (2023)

Insulin resistance, adipose tissue and coronary heart disease.
de réir: Frayn, K, et al.
Foilsithe / Cruthaithe: (1992)

Stroke, coronary heart disease, cholesterol and blood pressure
de réir: Lewington, S, et al.
Foilsithe / Cruthaithe: (1997)

Postprandial lipid metabolism in relation to coronary heart disease.
de réir: Karpe, F
Foilsithe / Cruthaithe: (1997)

Anthropometric characteristics as predictors of coronary heart disease in women
de réir: Yang, L, et al.
Foilsithe / Cruthaithe: (2008)

Fibrinogen and coronary heart disease: test of causality by 'Mendelian randomization'.
de réir: Keavney, B, et al.
Foilsithe / Cruthaithe: (2006)

Internet-based interventions for the secondary prevention of coronary heart disease
de réir: Devi, R, et al.
Foilsithe / Cruthaithe: (2015)

Oxidized phospholipids, Lp(a) and coronary heart disease risk
de réir: Clarke, R, et al.
Foilsithe / Cruthaithe: (2012)

Plasma cytokines and risk of coronary heart disease in the PROCARDIS study
de réir: Clarke, R, et al.
Foilsithe / Cruthaithe: (2018)

Association of Helicobacter pylori infection with coronary heart disease. Eradication of the infection on grounds of cardiovascular risk is not supported by current evidence.
de réir: Delaney, B, et al.
Foilsithe / Cruthaithe: (1996)

Subsequent event risk in individuals with established coronary heart disease
de réir: Patel, R, et al.
Foilsithe / Cruthaithe: (2019)

Framingham risk equations underestimate coronary heart disease risk in diabetes.
de réir: Stevens, R, et al.
Foilsithe / Cruthaithe: (2005)

Blood pressure and coronary heart disease: a review of the evidence.
de réir: Lawes, C, et al.
Foilsithe / Cruthaithe: (2002)